Huss, Andre and Bachhuber, Franziska and Feraudet-Tarisse, Cecile and Hiergeist, Andreas and Tumani, Hayrettin (2024) Multiple Sclerosis and Clostridium perfringens Epsilon Toxin: Is There a Relationship? BIOMEDICINES, 12 (7): 1392. ISSN ,2227-9059
Full text not available from this repository. (Request a copy)Abstract
Recent research has suggested a link between multiple sclerosis and the gut microbiota. This prospective pilot study aimed to investigate the composition of the gut microbiota in MS patients, the presence of Clostridium perfringens epsilon toxin in the serum of MS patients, and the influence of disease-modifying drugs (DMDs) on epsilon toxin levels and on the microbiota. Epsilon toxin levels in blood were investigated by two methods, a qualitative ELISA and a highly sensitive quantitative ELISA. Neither epsilon toxin nor antibodies against it were detected in the analyzed serum samples. 16S ribosomal RNA sequencing was applied to obtain insights into the composition of the gut microbiota of MS patients. No significant differences in the quantity, diversity, and the relative abundance of fecal microbiota were observed in the gut microbiota of MS patients receiving various DMDs, including teriflunomide, natalizumab, ocrelizumab, and fingolimod, or no therapy. The present study did not provide evidence supporting the hypothesis of a causal relationship between Clostridium perfringens epsilon toxin and multiple sclerosis.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | MICROBIOTA; ANTIBODIES; multiple sclerosis; Clostridium perfringens; C. perfringens epsilon toxin; microbiota |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 22 Jan 2026 06:01 |
| Last Modified: | 22 Jan 2026 06:01 |
| URI: | https://pred.uni-regensburg.de/id/eprint/65213 |
Actions (login required)
 |
View Item |
